Through 31-51-10

  1. Law
  2. Georgia Code
  3. Health
  4. Creation of Low Thc Oil Research Program
  5. Through 31-51-10

Checkout our iOS App for a better way to browser and research.

Repealed pursuant to Code Section 31-51-10, which provided for the repeal of this chapter, effective July 1, 2020.

Editor's notes.

- This chapter consisted of Code Sections 31-51-1 through 31-51-10, relating to the creation of a low THC oil research program, and was based on Ga. L. 2015, p. 49, § 4-1/HB 1; Ga. L. 2016, p. 864, § 31/HB 737.

CHAPTER 52 TERMINALLY ILL PATIENT'S RIGHT TO TRY INVESTIGATIONAL DRUGS, BIOLOGICAL PRODUCTS, AND DEVICES

Sec.

  • 31-52-1. Short title.
  • 31-52-2. Legislative findings.
  • 31-52-3. Definitions.
  • 31-52-4. Eligibility criteria.
  • 31-52-5. Written informed consent.
  • 31-52-6. Manufacturers permitted to make investigational drugs, biological products, or devices available.
  • 31-52-7. Coverage under health benefit plan permitted but not required.
  • 31-52-8. Physician immunity from sanction for recommending, prescribing, or treating with investigational drugs, biological products, or devices.
  • 31-52-9. State prohibited from blocking eligible patient access.
  • 31-52-10. Statutory construction.


Download our app to see the most-to-date content.